U.S. Homecare Corp., Hartsdale, N.Y., said it is exploring various alternatives including the possible sale or merger of the company.
The provider of in-home nursing services and intravenous therapies said it has retained investment banking firm Donaldson, Lufkin & Jenrette Securities Corp. to assist in the study.
The company provides services to 4,000 patients weekly, mainly in the New York metropolitan and tri-state area.
In Nasdaq Stock Market trading, the stock closed at $4, unchanged.
The company has about eight million shares outstanding.
For the nine months ended Sept. 30, it had a net loss of $2.9 million, or 36 cents a share, on revenue of $69.6 million.
